Huifeng Bio-Pharmaceutical Technology, Inc., the leader in developing and producing plant extracts, pharmaceuticals and pharmaceutical raw materials in mainland China and internationally, today reported its fourth quarter and year 2006 results ended December 31, 2006.

For the 12 months ended December 31, 2006, revenue was up 26% to $3,076,779 compared to $2,443,060 for year-end 2005. Net income for 2006 was $131,736 compared to a loss of ($832,767) for 2005. Earnings per share for 2006 increased to $.01 versus a loss of ($.11) for 2005. Huifeng's overall profit margin increased from 6% in 2005 to 15% in 2006.

For the fourth quarter ended December 31, 2006, revenue was $679,991 compared to $64,272 for the fourth quarter ended December 31, 2005. Net income for the fourth quarter 2006 was a loss of ($18,569) versus a loss of ($983,072) for the fourth quarter 2005. Earnings per share in the fourth quarter was ($.01) compared to a loss of ($.13) in the fourth quarter 2005.

Source:佚名